Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://harmonyzanw483340.shotblogs.com/retaglutide-a-promising-glp-1-receptor-agonist-52968295